SOLENO THERAPEUTICS INC 4 SEC Filings

Filed On	Filing
18 May 2026	Form 4: Volck Birgitte, Director Returned 17,536 shares to the issuer · Disposed of 22,090 Stock Option (Right to buy) (Disposition to Issuer)
18 May 2026	Form 4: Sinclair Andrew, Director Returned 10,491 shares to the issuer · Disposed of 22,913 Stock Option (Right to buy) (Disposition to Issuer)
18 May 2026	Form 4: Pauls Matthew, Director Returned 10,491 shares to the issuer · Disposed of 9,063 Stock Option (Right to buy) (Disposition to Issuer)
18 May 2026	Form 4: Norrett Kevin, Chief Business Officer Returned 17,786 shares to the issuer · Disposed of 68,286 Stock Option (Right to buy) (Disposition to Issuer)
18 May 2026	Form 4: Manning Meredith, Chief Commercial Officer Returned 64,507 shares to the issuer · Disposed of 91,000 Employee stock option (right to buy) (Disposition to Issuer) · Disposed of 62,000 Employee Stock Option (Right to buy) (Disposition to Issuer)
18 May 2026	Form 4: Joshi Manher, Chief Development Officer Returned 20,171 shares to the issuer · Disposed of 77,021 Stock Option (Right to buy) (Disposition to Issuer)
18 May 2026	Form 4: Huang Michael F., Sr. VP of Clinical Development Returned 39,823 shares to the issuer · Disposed of 135,700 Stock Option (Right to buy) (Disposition to Issuer)
18 May 2026	Form 4: Hirano Patricia C, SEE REMARKS Returned 22,702 shares to the issuer · Disposed of 126,249 Employee Stock Option (Right to buy) (Disposition to Issuer) · Disposed of 1,333 Warrant (Right to buy) (Disposition to Issuer)
18 May 2026	Form 4: Hahn Mark W, Director Returned 10,046 shares to the issuer
18 May 2026	Form 4: Fulk Jennifer, CHIEF FINANCIAL OFFICER Returned 39,200 shares to the issuer · Disposed of 67,660 Employee Stock Option (Right to buy) (Disposition to Issuer)
18 May 2026	Form 4: Bir Dawn Carter, Director Returned 16,991 shares to the issuer
18 May 2026	Form 4: Yen Kristen, SEE REMARKS Returned 37,639 shares to the issuer · Disposed of 141,410 Employee Stock Option (Right to buy) (Disposition to Issuer)
18 May 2026	Form 4: Anish Bhatnagar, Director Returned 583,656 shares to the issuer · Disposed of 763,112 Employee Stock Option (Right to buy) (Disposition to Issuer)
31 Mar 2026	Form 4: Manning Meredith, Chief Commercial Officer Sold 7,522 shares ($229K)
31 Mar 2026	Form 4: Huang Michael F., Sr. VP of Clinical Development Sold 6,582 shares ($200K)
04 Mar 2026	Form 4: Fulk Jennifer, CHIEF FINANCIAL OFFICER Received 39,200 shares as a grant or award · Acquired 67,660 Employee stock option (right to buy) (Option Exercise/Conversion)
23 Jan 2026	Form 4: Yen Kristen, SEE REMARKS Received 10,400 shares as a grant or award · Granted 11,900 Employee stock option (right to buy)
23 Jan 2026	Form 4: Manning Meredith, Chief Commercial Officer Received 28,600 shares as a grant or award · Granted 32,800 Employee stock option (right to buy)
23 Jan 2026	Form 4: Mackaness James H, CHIEF FINANCIAL OFFICER Received 28,600 shares as a grant or award · Granted 32,800 Employee stock option (right to buy)
23 Jan 2026	Form 4: Joshi Manher, Chief Development Officer Received 4,100 shares as a grant or award · Granted 4,700 Employee stock option (right to buy)

Comments